Drug Pricing Center
![pills-943764_1920[1]](https://eadn-wc03-6094147.nxedge.io/wp-content/uploads/2015/01/pills-943764_19201-1500x430.jpg)
Resources
Five Years of State Action to Lower Drug Prices: 2017-2021, May 2021
Pharmacy Cost Work Group MembersEd Achuck, Pharmacy Section Chief, California Department of General Services
Susan Barrett, Executive Director, Green Mountain Care Board, Vermont
Burl Beasley, Director, Pharmacy Services, Oklahoma Office of Management and Enterprise Services
Terry Cothran, Senior Pharmacy Director, Oklahoma Health Care Authority
James DeBenedetti, Director of Plan Management, Covered California
Richard Gottfried, State Assemblyman and Chair of Committee on Health, New York State Assembly, District 75
Kaha Hizanishvili, Chief, Provider and Pharmacy Programs, MassHealth, Massachussetts Executive Office of Health and Human Services
Sonya Jaquez Lewis, State Senator, Colorado State Senate, District 17
Eileen Mallow, Director, Office of Strategic Health Policy, Wisconsin Department of Employee Trust Funds
Kevin Martin, Pharmacy Rates Analyst, Colorado Department of Health Care Policy and Financing
Sara Sadownik, Deputy Director, Research and Cost Trends, Massachusetts Health Policy Commission
David Seltz, Executive Director, Massachusetts Health Policy Commission
Tricia Sieg, Pharmacy Benefit Program Manager, Wisconsin Department of Employee Trust Funds
Donna Sullivan, Chief Pharmacy Officer, Washington State Health Care Authority
Norman Thurston, State Representative, Utah House of Representatives, District 64
Joshua Wojcik, Assistant Comptroller, Connecticut Office of the Comptroller
Andrew York, Executive Director, Maryland Prescription Drug Affordability Board
To learn more about the Center or to receive state-only materials contact Jennifer Reck (jreck@oldsite.nashp.org)
Sign Up for Our Weekly Newsletter
Sign Up for Our Weekly Newsletter
Washington, DC Office:
1233 20th St., N.W., Suite 303Washington, DC 20036
p: (202) 903-0101
f: (202) 903-2790
Contact Us
Phone: 202-903-0101

For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 
























































































































































Webinar Addresses Rising Cost of Pharmaceuticals
/in Policy Webinars Cost, Payment, and Delivery Reform, Prescription Drug Pricing /by NASHP WritersStates and the Rising Cost of Pharmaceuticals: A Call to Action
/in Policy Reports Administrative Actions, Cost, Payment, and Delivery Reform, Health System Costs, Prescription Drug Pricing, State Rx Legislative Action /by NASHP Pharmacy Costs Work GroupAs part of the 29th Annual State Health Policy Conference, held 17-19 in Pittsburgh, PA, NASHP released findings from our Pharmacy Costs Work Group aimed at addressing the increasingly rising costs of pharmaceuticals. The solutions offered in the newly released findings serve as a toolbox for states. While they recognize the value of the pharmaceutical industry, state policymakers […]
State Leaders Offer Solutions to Address Rapid Increase in Prescription Drug Spending
/in Policy Blogs Administrative Actions, Cost, Payment, and Delivery Reform, Health System Costs, Prescription Drug Pricing, State Rx Legislative Action /by NASHP Pharmacy Costs Work GroupNew Findings from Rx Work Group Released at National Health Event Pittsburgh, PA – The National Academy for State Health Policy (NASHP) today released findings from their Pharmacy Costs Work Group aimed at addressing the increasingly rising costs of pharmaceuticals. The findings were released as part of their 29th Annual State Health Policy Conference, held […]
NASHP Announces Pharmacy Costs Work Group
/in Policy Blogs Administrative Actions, Health Coverage and Access, Prescription Drug Pricing, State Rx Legislative Action /by Lesa RairThe newly launched National Academy for State Health Policy (NASHP) Pharmacy Cost Work Group will look beyond the strategies currently used in states to identify and develop new ideas which address the growing problem of Rx costs. The group will look broadly at states as purchasers, regulators, policymakers, and investors to develop the next generation […]
New Law to Curb Opioid Abuse and Diversion Passed in Maine, Strengthens Prescription Drug Monitoring Program
/in Policy Maine Blogs Behavioral/Mental Health and SUD, Chronic and Complex Populations, Chronic Disease Prevention and Management, Population Health, Prescription Drug Pricing /by Lesa RairGovernor Paul LePage signed into law “An Act to Prevent Opiate Abuse by Strengthening the Controlled Substances Prescription Monitoring Program” (now PL 2015, c. 488) on April 19, 2016, making Maine the second state to pass legislation on the issue this year. In March, Massachusetts passed the nation’s first law limiting first-time opioid prescriptions. Maine’s […]
States and Prescription Drugs: An Overview of State Programs to Rein in Costs
/in Policy Reports Administrative Actions, Cost, Payment, and Delivery Reform, Essential Health Benefits, Health Coverage and Access, Health System Costs, Medicaid Expansion, Medicaid Managed Care, Prescription Drug Pricing, State Rx Legislative Action /by Ellen SchneiterStates are significant purchasers of health care for Medicaid, inmates in correctional facilities, and public employees. Despite considerable efforts to maintain affordability, drug pricing continues to vex state budgets. While Medicaid is the largest single health expenditure in state budgets, spending on health care for public workers including state employees and retirees, legislators, judicial employees, […]